Sunitinib (Sutent): Comprehensive Clinical Overview for Pharmacists
1. Introduction Sunitinib mesylate (Sutent®) is a multikinase inhibitor approved by the FDA and EMA for several advanced malignancies. It is classified as a targeted therapy, specifically a tyrosine kinase…
